Chargement en cours...
Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment
Immune checkpoint‐blocking antibodies have therapeutic activity against relapsed or progressive classic Hodgkin lymphoma (cHL), but Hodgkin Reed‐Sternberg cells can develop resistance to this therapy via multiple mechanisms. To improve the efficacy of immune checkpoint blockade, we need a more preci...
Enregistré dans:
| Publié dans: | Cancer Med |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558469/ https://ncbi.nlm.nih.gov/pubmed/31070022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2168 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|